Cargando…
Parenteral high-dose ascorbate - A possible approach for the treatment of glioblastoma (Review)
For glioblastoma, the treatment with standard of care therapy comprising resection, radiation, and temozolomide results in overall survival of approximately 14-18 months after initial diagnosis. Even though several new therapy approaches are under investigation, it is difficult to achieve life prolo...
| Autores principales: | , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
D.A. Spandidos
2021
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8104923/ https://www.ncbi.nlm.nih.gov/pubmed/33955499 http://dx.doi.org/10.3892/ijo.2021.5215 |